Length of therapy with selective serotonin reuptake inhibitors and tricyclic antidepressants in Australia

References

• Shea M T, Elkin I, Imber SD, et al. Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Archives of General Psychiatry 1992; 49: 782–787
   PubMed Web of Science ®Google Scholar
• Geddes J R, Carney S M, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003; 361: 653–661
   PubMed Web of Science ®Google Scholar
• Harrison P. Depression needs prophylactic treatment. Australian Doctor Weekly 1992; 55, 26 June
   Google Scholar
• Agency for Health Care Policy and Research. Depression in primary care: Vol. 2. Treatment of major depression. AHCPR, US Department of Health and Human Services, Rockville, MD 1993
   Google Scholar
• Keller M B. The long-term treatment of depression. Journal of Clinical Psychiatry 1999; 60(Suppl. 17)41–45
   PubMedGoogle Scholar
• Therapeutic Guidelines. Therapeutic guidelines: psychotropic, version 4. Therapeutic Guidelines, Melbourne 2000, http://www.tg.com.au
   Google Scholar
• Commonwealth Department of Health and Aged Care. Australian statistics on medicines 1998. AusInfo, Canberra 1999
   Google Scholar
• Anderson I M, Tomenson B M. Treatment continuation with selective serontonin reuptake inhibitors compared to tricyclic antidepressants: a meta-analysis. British Medical Journal 1995; 310: 1433–1438
   PubMed Web of Science ®Google Scholar
• Hotopf M, Hardy R, Lewis G. Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. British Journal of Psychiatry 1997; 170: 120–127
   PubMed Web of Science ®Google Scholar
• Martin R M, Hilton S R, Kerry S M, Richards N M. General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants. British Medical Journal 1997; 314: 646–651
   PubMed Web of Science ®Google Scholar
• Lawrenson R. Pattern of antidepressant prescription in general practice: lessons from the MediPlus database. Primary Care Psychiatry 1999; 5: S3–S7
   Google Scholar
• McManus P, Mant A, Mitchell P, Birkett D, Dudley J. Co-prescribing of SSRIs and TCAs in Australia: how often does it occur and who is doing it?. British Journal of Clinical Pharmacology 2001; 51: 93–98
   PubMed Web of Science ®Google Scholar
• McManus P, Birkett D J, Mant A. Prescription use by patients with concession cards. Medical Journal of Australia 1998; 169: 285–286
   PubMedGoogle Scholar
• McManus P, Mant A, Mitchell P B, Montgomery W S, Marley J, Auland M E. Recent trends in the use of antidepressant drugs in Australia, 1990–98. Medical Journal of Australia 2000; 173: 458–461
   PubMed Web of Science ®Google Scholar
• StataCorp. Stata statistical software: release 6.0. StataCorp, College Station, TX 1999
   Google Scholar
• Altamura A, Percudani M. The use of antidepressants for long-term treatment of recurrent depression: rationale, current methodologies, and future direction. Journal of Clinical Psychiatry 1993; 54(Suppl. 8)29–38
   PubMedGoogle Scholar
• Maj M, Veltro F, Pirozzi R, Lobrace S, Magliano L. Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study. American Journal of Psychiatry 1992; 149: 795–800
   PubMed Web of Science ®Google Scholar
• McManus P, Mant A, Mitchell P, Britt H, Dudley J. Use of antidepressants by general practitioners and psychiatrists in Australia. Australia and New Zealand Journal of Psychiatry 2003; 37: 184–189
   PubMed Web of Science ®Google Scholar
• Judd F, Boyce P. Tricyclic antidepressants in the treatment of depression. Australian Family Physician 1999; 28: 809–813
   PubMedGoogle Scholar
• Song F, Freemantle N, Sheldon T, et al. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. British Medical Journal 1993; 306: 683–687
   PubMed Web of Science ®Google Scholar
• Rosholm J U, Gram L F, Isacsson G, Hallas J, Bergman U. Changes in the pattern of antidepressant use upon the introduction of the new antidepressants: a prescription database study. European Journal of Clinical Pharmacology 1997; 52: 205–209
   PubMed Web of Science ®Google Scholar
• Kamolz T. Analysis of medical compliance in gastro-oesophageal reflux disease patients referred to pre-surgical examination. Digestive and Liver Disease 2002; 34: 183–189
   Google Scholar
• Stewart R B, Caranasos G J. Medication compliance in the elderly. Medical Clinics of North America 1989; 73: 1551–1563
   PubMed Web of Science ®Google Scholar
• Mant A, Duncan-Jones P, Saltman D, et al. Development of long term use of psychotropic drugs by general practice patients. British Medical Journal 1988; 296: 251–254
   PubMed Web of Science ®Google Scholar
• Demyttenaere K, Enzlin P, Dewe W, et al. Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse events. Journal of Clinical Psychiatry 2001; 62(Suppl. 22)30–33
   PubMed Web of Science ®Google Scholar
• Frank E, Judge R. Treatment recommendations versus treatment realities. Journal of Clinical Psychiatry 2001; 62(Suppl. 21)10–15
   PubMedGoogle Scholar